| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |